These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24933320)

  • 41. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
    Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
    Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.
    Makino K; Makino T; Stawski L; Mantero JC; Lafyatis R; Simms R; Trojanowska M
    J Invest Dermatol; 2017 Aug; 137(8):1671-1681. PubMed ID: 28433542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung.
    Bhattacharyya S; Wang W; Qin W; Cheng K; Coulup S; Chavez S; Jiang S; Raparia K; De Almeida LMV; Stehlik C; Tamaki Z; Yin H; Varga J
    JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars.
    Bellemare J; Roberge CJ; Bergeron D; Lopez-Vallé CA; Roy M; Moulin VJ
    J Pathol; 2005 May; 206(1):1-8. PubMed ID: 15772942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of Aquaporin3 in Systemic Sclerosis Dermal Fibroblasts.
    Yousefi B; Mahmoudi M; Sarafnejad A; Karimizadeh E; Farhadi E; Jamshidi AR; Kavosi H; Aslani S; Gharibdoost F
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):228-234. PubMed ID: 28732436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Panx1 regulates cellular properties of keratinocytes and dermal fibroblasts in skin development and wound healing.
    Penuela S; Kelly JJ; Churko JM; Barr KJ; Berger AC; Laird DW
    J Invest Dermatol; 2014 Jul; 134(7):2026-2035. PubMed ID: 24522432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-36α is elevated in diffuse systemic sclerosis and may potentiate fibrosis.
    O'Reilly S
    Cytokine; 2022 Aug; 156():155921. PubMed ID: 35667282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis.
    Henrot P; Moisan F; Laurent P; Manicki P; Kaulanjan-Checkmodine P; Jolivel V; Rezvani HR; Leroy V; Picard F; Boulon C; Schaeverbeke T; Seneschal J; Lazaro E; Taïeb A; Truchetet ME; Cario M
    J Invest Dermatol; 2020 Jul; 140(7):1427-1434.e5. PubMed ID: 31954725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
    Man XY; Finnson KW; Baron M; Philip A
    Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
    Laurent P; Allard B; Manicki P; Jolivel V; Levionnois E; Jeljeli M; Henrot P; Izotte J; Leleu D; Groppi A; Seneschal J; Constans J; Chizzolini C; Richez C; Duffau P; Lazaro E; Forcade E; Schaeverbeke T; Pradeu T; Batteux F; Blanco P; Contin-Bordes C; Truchetet ME
    Ann Rheum Dis; 2021 Dec; 80(12):1594-1603. PubMed ID: 34285051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible roles of barrier-to-autointegration factor 1 in regulation of keratinocyte differentiation and proliferation.
    Takama H; Sugiura K; Ogawa Y; Muro Y; Akiyama M
    J Dermatol Sci; 2013 Aug; 71(2):100-6. PubMed ID: 23664529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis.
    Almadori A; Griffin M; Ryan CM; Hunt DF; Hansen E; Kumar R; Abraham DJ; Denton CP; Butler PEM
    PLoS One; 2019; 14(7):e0218068. PubMed ID: 31314805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis.
    Yasuoka H; Yamaguchi Y; Feghali-Bostwick CA
    PLoS One; 2014; 9(2):e87754. PubMed ID: 24551065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rac inhibition reverses the phenotype of fibrotic fibroblasts.
    Xu SW; Liu S; Eastwood M; Sonnylal S; Denton CP; Abraham DJ; Leask A
    PLoS One; 2009 Oct; 4(10):e7438. PubMed ID: 19823586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.
    Beyer C; Schramm A; Akhmetshina A; Dees C; Kireva T; Gelse K; Sonnylal S; de Crombrugghe B; Taketo MM; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2012 May; 71(5):761-7. PubMed ID: 22328737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis.
    Worrell JC; Leslie J; Smith GR; Zaki MYW; Paish HL; Knox A; James ML; Cartwright TN; O'Reilly S; Kania G; Distler O; Distler JHW; Herrick AL; Jeziorska M; Borthwick LA; Fisher AJ; Mann J; Mann DA; Oakley F
    Rheumatology (Oxford); 2020 Dec; 59(12):3939-3951. PubMed ID: 32725139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interplay Between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders.
    Russo B; Brembilla NC; Chizzolini C
    Front Immunol; 2020; 11():648. PubMed ID: 32477322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.